B Positive – all you wanted to know about - ASHM
B Positive – all you wanted to know about - ASHM
B Positive – all you wanted to know about - ASHM
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
9 Hepatitis B virus related hepa<strong>to</strong>cellular carcinoma<br />
27. bruix J, sherman M. Management of<br />
hepa<strong>to</strong>cellular carcinoma. Hepa<strong>to</strong>logy<br />
2005;42(5):1208-36.<br />
28. Perry Jf, Poustchi H, George J, farrell Gc,<br />
Mccaughan GW, strasser si. current<br />
approaches <strong>to</strong> the diagnosis and<br />
management of hepa<strong>to</strong>cellular carcinoma.<br />
clin exp Med 2005;5(1):1-13.<br />
29. Kawano n, ohmori y, inoue s, nagao<br />
t, Morioka y. Long-term prognosis of<br />
surgical patients with hepa<strong>to</strong>cellular<br />
carcinoma. cancer chemother Pharmacol<br />
1989;23(suppl):s129-32.<br />
30. Llovet JM, schwartz M, Mazzaferro V.<br />
resection and liver transplantation for<br />
hepa<strong>to</strong>cellular carcinoma. semin Liver dis<br />
2005;25(2):181-200.<br />
31. cha c, fong y, Jarnagin Wr, blumgart LH,<br />
deMatteo rP. Predic<strong>to</strong>rs and patterns of<br />
recurrence after resection of hepa<strong>to</strong>cellular<br />
carcinoma. J am coll surg 2003;197(5):753-8.<br />
32. belghiti J. transplantation for liver tumors.<br />
semin oncol 2005;32(6 suppl 8):s29-s32.<br />
33. Mazzaferro V, regalia e, doci r, andreola<br />
s, Pulvirenti a, bozzetti f, et al. Liver<br />
transplantation for the treatment of sm<strong>all</strong><br />
hepa<strong>to</strong>cellular carcinomas in patients with<br />
cirrhosis. n engl J Med 1996;334(11):693-<br />
700.<br />
34. Hemming aW, cattral Ms, reed ai, Van<br />
der Werf WJ, Greig Pd, Howard rJ. Liver<br />
transplantation for hepa<strong>to</strong>cellular carcinoma.<br />
ann surg 2001;233(5):652-9.<br />
35. Llovet JM, fuster J, bruix J. intention-<strong>to</strong>treat<br />
analysis of surgical treatment for early<br />
hepa<strong>to</strong>cellular carcinoma: resection versus<br />
transplantation. Hepa<strong>to</strong>logy 1999;30(6):1434-<br />
40.<br />
36. Kawamo<strong>to</strong> c, ido K, isoda n, nagamine n,<br />
Hozumi M, ono K, et al. Prognosis of sm<strong>all</strong><br />
hepa<strong>to</strong>cellular carcinoma after laparoscopic<br />
ethanol injection. Gastrointest endosc<br />
1999;50(2):214-20.<br />
37. ohnishi K, nomura f, i<strong>to</strong> s, fujiwara K.<br />
Prognosis of sm<strong>all</strong> hepa<strong>to</strong>cellular carcinoma<br />
(less than 3 cm) after percutaneous acetic<br />
acid injection: study of 91 cases. Hepa<strong>to</strong>logy<br />
1996;23(5):994-1002.<br />
38. bruix J, castells a, Montanya X, calvet X, bru<br />
c, ayuso c, et al. Phase ii study of transarterial<br />
embolization in european patients with<br />
hepa<strong>to</strong>cellular carcinoma: need for controlled<br />
trials. Hepa<strong>to</strong>logy 1994;20(3):643-50.<br />
74 b <strong>Positive</strong> <strong>–</strong> <strong>all</strong> <strong>you</strong> <strong>wanted</strong> <strong>to</strong> <strong>know</strong> <strong>about</strong> hepatitis b: a guide for primary care providers<br />
39. ando e, tanaka M, yamashita f, Kuromatsu<br />
r, yutani s, fukumori K, et al. Hepatic arterial<br />
infusion chemotherapy for advanced<br />
hepa<strong>to</strong>cellular carcinoma with portal vein<br />
tumor thrombosis: analysis of 48 cases.<br />
cancer 2002;95(3):588-95.<br />
40. ni yH, chang MH, Huang LM, chen HL, Hsu<br />
Hy, chiu ty, et al. Hepatitis b virus infection in<br />
children and adolescents in a hyperendemic<br />
area: 15 years after mass hepatitis b<br />
vaccination. ann intern Med 2001;135(9):796-<br />
800.<br />
41. chang MH, chen cJ, Lai Ms, Hsu HM, Wu<br />
tc, Kong Ms, et al. universal hepatitis b<br />
vaccination in taiwan and the incidence of<br />
hepa<strong>to</strong>cellular carcinoma in children. taiwan<br />
childhood Hepa<strong>to</strong>ma study Group. n engl J<br />
Med 1997;336(26):1855-9.<br />
42. Kao J, chen d. overview of hepatitis b and c<br />
viruses. in: Goedert J, edi<strong>to</strong>r. infectious causes<br />
of cancer. <strong>to</strong><strong>to</strong>wa, nJ, usa: Humana Press inc,<br />
2006:313-30.<br />
43. craxi a, camma c. Prevention of<br />
hepa<strong>to</strong>cellular carcinoma. clin Liver dis<br />
2005;9(2):329-46, viii.<br />
44. fung sK, Lok as. treatment of chronic<br />
hepatitis b: who <strong>to</strong> treat, what <strong>to</strong> use, and<br />
for how long? clin Gastroenterol Hepa<strong>to</strong>l<br />
2004;2(10):839-48.<br />
45. Lai cJ, terrault na. antiviral therapy in<br />
patients with chronic hepatitis b and cirrhosis.<br />
Gastroenterol clin north am 2004;33(3):629-<br />
54, x-xi.<br />
46. Lok as, McMahon bJ. american association<br />
for the study of Liver diseases Practice<br />
Guidelines. chronic Hepatitis b. Hepa<strong>to</strong>logy<br />
2007;45(2):507-39.<br />
47. Hache c, Villeneuve JP. Lamivudine<br />
treatment in patients with chronic hepatitis<br />
b and cirrhosis. expert opin Pharmacother<br />
2006;7(13):1835-43.<br />
48. sherman M. Pathogenesis and screening<br />
for hepa<strong>to</strong>cellular carcinoma. clin Liver dis<br />
2004;8(2):419-43, viii.<br />
49. robinson t, bullen c, Humphries W, Hornell<br />
J, Moyes c. the new Zealand Hepatitis b<br />
screening Programme: screening coverage<br />
and prevalence of chronic hepatitis b<br />
infection. nZ Med J 2005;118(1211):u1345.<br />
50. centers for disease control and Prevention<br />
(cdc). screening for chronic hepatitis b<br />
among asian/Pacific islander populationsnew<br />
york city, 2005.MMWr Morb Mortal<br />
Wkly rep 2006;55(18):505-509.
Change language